Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 28-Feb 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4698009013 | Product containing precisely drotaverine hydrochloride 80 milligram and mefenamic acid 250 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4698010015 | Drotaverine hydrochloride 80 mg and mefenamic acid 250 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely drotaverine hydrochloride 80 milligram and mefenamic acid 250 milligram/1 each conventional release oral tablet (clinical drug) | a une forme pharmaceutique (attribut) | Oral tablet | true | Inferred relationship | Some | ||
| Product containing precisely drotaverine hydrochloride 80 milligram and mefenamic acid 250 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely drotaverine hydrochloride 80 milligram and mefenamic acid 250 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Drotaverine hydrochloride (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely drotaverine hydrochloride 80 milligram and mefenamic acid 250 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Drotaverine hydrochloride (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely drotaverine hydrochloride 80 milligram and mefenamic acid 250 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 1 | |
| Product containing precisely drotaverine hydrochloride 80 milligram and mefenamic acid 250 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely drotaverine hydrochloride 80 milligram and mefenamic acid 250 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Mefenamic acid (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely drotaverine hydrochloride 80 milligram and mefenamic acid 250 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Mefenamic acid (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely drotaverine hydrochloride 80 milligram and mefenamic acid 250 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 2 | |
| Product containing precisely drotaverine hydrochloride 80 milligram and mefenamic acid 250 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
| Product containing precisely drotaverine hydrochloride 80 milligram and mefenamic acid 250 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Drotaverine and mefenamic acid only product in oral dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Canada English language reference set (foundation metadata concept)
FHIR